Tags

Type your tag names separated by a space and hit enter

Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry.
Rapid Commun Mass Spectrom. 2009 Jan; 23(1):65-76.RC

Abstract

Proper storage conditions of biological samples are fundamental to avoid microbiological contamination that can cause chemical modifications of the target analytes. A simple liquid chromatography/tandem mass spectrometry (LC/MS/MS) method through direct injection of diluted samples, without prior extraction, was used to evaluate the stability of phase II metabolites of boldenone and testosterone (glucuronides and sulphates) in intentionally poorly stored equine urine samples. We also considered the stability of some deuterated conjugated steroids generally used as internal standards, such as deuterated testosterone and epitestosterone glucuronides, and deuterated boldenone and testosterone sulphates. The urines were kept for 1 day at room temperature, to mimic poor storage conditions, then spiked with the above steroids and kept at different temperatures (-18 degrees C, 4 degrees C, room temperature). It has been possible to confirm the instability of glucuronide compounds when added to poorly stored equine urine samples. In particular, both 17beta- and 17alpha-glucuronide steroids were exposed to hydrolysis leading to non-conjugated steroids. Only 17beta-hydroxy steroids were exposed to oxidation to their keto derivatives whereas the 17alpha-hydroxy steroids were highly stable. The sulphate compounds were completely stable. The deuterated compounds underwent the same behaviour as the unlabelled compounds. The transformations were observed in urine samples kept at room temperature and at a temperature of 4 degrees C (at a slower rate). No modifications were observed in frozen urine samples. In the light of the latter results, the immediate freezing at -18 degrees C of the collected samples and their instant analysis after thawing is the proposed procedure for preventing the transformations that occur in urine, usually due to microbiological contamination.

Authors+Show Affiliations

UNIRE Lab. Srl, Via Gramsci 70, 20019 Settimo Milanese (MI), Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Validation Study

Language

eng

PubMed ID

19051232

Citation

Fidani, M, et al. "Evaluation of Equine Urine Reactivity Towards Phase II Metabolites of 17-hydroxy Steroids By Liquid Chromatography/tandem Mass Spectrometry." Rapid Communications in Mass Spectrometry : RCM, vol. 23, no. 1, 2009, pp. 65-76.
Fidani M, Gamberini MC, Pasello E, et al. Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23(1):65-76.
Fidani, M., Gamberini, M. C., Pasello, E., Palazzoli, F., De Iuliis, P., Montana, M., & Arioli, F. (2009). Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry : RCM, 23(1), 65-76. https://doi.org/10.1002/rcm.3858
Fidani M, et al. Evaluation of Equine Urine Reactivity Towards Phase II Metabolites of 17-hydroxy Steroids By Liquid Chromatography/tandem Mass Spectrometry. Rapid Commun Mass Spectrom. 2009;23(1):65-76. PubMed PMID: 19051232.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry. AU - Fidani,M, AU - Gamberini,M C, AU - Pasello,E, AU - Palazzoli,F, AU - De Iuliis,P, AU - Montana,M, AU - Arioli,F, PY - 2008/12/4/pubmed PY - 2009/3/13/medline PY - 2008/12/4/entrez SP - 65 EP - 76 JF - Rapid communications in mass spectrometry : RCM JO - Rapid Commun. Mass Spectrom. VL - 23 IS - 1 N2 - Proper storage conditions of biological samples are fundamental to avoid microbiological contamination that can cause chemical modifications of the target analytes. A simple liquid chromatography/tandem mass spectrometry (LC/MS/MS) method through direct injection of diluted samples, without prior extraction, was used to evaluate the stability of phase II metabolites of boldenone and testosterone (glucuronides and sulphates) in intentionally poorly stored equine urine samples. We also considered the stability of some deuterated conjugated steroids generally used as internal standards, such as deuterated testosterone and epitestosterone glucuronides, and deuterated boldenone and testosterone sulphates. The urines were kept for 1 day at room temperature, to mimic poor storage conditions, then spiked with the above steroids and kept at different temperatures (-18 degrees C, 4 degrees C, room temperature). It has been possible to confirm the instability of glucuronide compounds when added to poorly stored equine urine samples. In particular, both 17beta- and 17alpha-glucuronide steroids were exposed to hydrolysis leading to non-conjugated steroids. Only 17beta-hydroxy steroids were exposed to oxidation to their keto derivatives whereas the 17alpha-hydroxy steroids were highly stable. The sulphate compounds were completely stable. The deuterated compounds underwent the same behaviour as the unlabelled compounds. The transformations were observed in urine samples kept at room temperature and at a temperature of 4 degrees C (at a slower rate). No modifications were observed in frozen urine samples. In the light of the latter results, the immediate freezing at -18 degrees C of the collected samples and their instant analysis after thawing is the proposed procedure for preventing the transformations that occur in urine, usually due to microbiological contamination. SN - 0951-4198 UR - https://www.unboundmedicine.com/medline/citation/19051232/Evaluation_of_equine_urine_reactivity_towards_phase_II_metabolites_of_17_hydroxy_steroids_by_liquid_chromatography/tandem_mass_spectrometry_ L2 - https://doi.org/10.1002/rcm.3858 DB - PRIME DP - Unbound Medicine ER -